ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 41 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $204,000 | -6.4% | 200,000 | 0.0% | 0.00% | – |
Q4 2020 | $218,000 | +5.8% | 200,000 | 0.0% | 0.00% | – |
Q3 2020 | $206,000 | -68.9% | 200,000 | -66.7% | 0.00% | -100.0% |
Q2 2020 | $662,000 | +117.0% | 600,000 | +100.0% | 0.00% | -33.3% |
Q1 2020 | $305,000 | -11.3% | 300,000 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $344,000 | – | 300,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TENOR CAPITAL MANAGEMENT Co., L.P. | 74,881,000 | $76,559,000 | 1.97% |
III Capital Management | 15,000,000 | $15,227,000 | 1.82% |
TFG Asset Management GP Ltd | 14,055,000 | $14,321,000 | 1.02% |
MACKAY SHIELDS LLC | 28,304,000 | $28,739,000 | 0.21% |
RWC Asset Management LLP | 6,500,000 | $6,604,000 | 0.20% |
PALISADE CAPITAL MANAGEMENT, LP | 7,187,000 | $7,281,000 | 0.17% |
CQS (US), LLC | 4,000,000 | $4,092,000 | 0.13% |
FARALLON CAPITAL MANAGEMENT LLC | 24,435,000 | $24,797,000 | 0.12% |
D. E. Shaw & Co., Inc. | 59,728,000 | $60,845,000 | 0.06% |
BNP Paribas Asset Management Holding S.A. | 7,000,000 | $7,133,000 | 0.03% |